Innovent, Chipscreen Biosciences to assess combination therapy in colorectal cancer patients

Image: Innovent announces a collaboration with Chipscreen Biosciences to evaluate the combination therapy in colorectal cancer patients. Photo: courtesy of jk1991/FreeDigitalPhotos.net.